Literature DB >> 1279208

Transfection-mediated recombination of influenza A virus.

M Bergmann1, A García-Sastre, P Palese.   

Abstract

Several mechanisms, including a high mutation rate and reassortment of genes, have been found to be responsible for the variability of influenza A viruses. RNA recombination would be another mechanism leading to genetic variation; however, recombination has only rarely been reported to occur in influenza viruses. During ribonucleoprotein transfection experiments designed to generate viable influenza viruses from in vitro-synthesized RNA, we discovered several viruses which must have originated from recombination events. The ribonucleoprotein transfection system may enhance the formation of viruses which result from jumping of the viral polymerase between RNAs or from ligation of different viral RNAs. Five different recombinant viruses are described. Two of these, REC1 and REC2, contain a neuraminidase (NA) gene whose defective polyadenylation signal has been repaired via intergenic recombination; 124 and 95 nucleotides have been added, respectively. Another virus, REC5, must have originated by multiple recombination events since it contains a mosaic gene with sequences derived from the NA gene of influenza A/WSN/33 virus and the matrix, polymerase protein PB1, and NA genes of influenza A/PR/8/34 virus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279208      PMCID: PMC240473          DOI: 10.1128/JVI.66.12.7576-7580.1992

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA.

Authors:  K Yamanaka; N Ogasawara; H Yoshikawa; A Ishihama; K Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

2.  The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure.

Authors:  G X Luo; W Luytjes; M Enami; P Palese
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 3.  RNA recombination in animal and plant viruses.

Authors:  M M Lai
Journal:  Microbiol Rev       Date:  1992-03

Review 4.  Genetic analysis of influenza virus.

Authors:  G Luo; P Palese
Journal:  Curr Opin Genet Dev       Date:  1992-02       Impact factor: 5.578

Review 5.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

6.  A new method for reconstituting influenza polymerase and RNA in vitro: a study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo.

Authors:  B L Seong; G G Brownlee
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

7.  An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice.

Authors:  T Muster; E K Subbarao; M Enami; B R Murphy; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

8.  High-efficiency formation of influenza virus transfectants.

Authors:  M Enami; P Palese
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

9.  Positive Darwinian evolution in human influenza A viruses.

Authors:  W M Fitch; J M Leiter; X Q Li; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

10.  An influenza virus containing nine different RNA segments.

Authors:  M Enami; G Sharma; C Benham; P Palese
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

View more
  18 in total

1.  HIV classification using the coalescent theory.

Authors:  Ingo Bulla; Anne-Kathrin Schultz; Fabian Schreiber; Ming Zhang; Thomas Leitner; Bette Korber; Burkhard Morgenstern; Mario Stanke
Journal:  Bioinformatics       Date:  2010-04-16       Impact factor: 6.937

2.  Transfection of HepG2 cells with infectious hepatitis C virus genome.

Authors:  S Dash; A B Halim; H Tsuji; N Hiramatsu; M A Gerber
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Reconstitution in cultured cells of replicating HDV RNA from pairs of less than full-length RNAs.

Authors:  Severin O Gudima; Jinhong Chang; John M Taylor
Journal:  RNA       Date:  2004-12-01       Impact factor: 4.942

4.  Homologous recombination is very rare or absent in human influenza A virus.

Authors:  Maciej F Boni; Yang Zhou; Jeffery K Taubenberger; Edward C Holmes
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

5.  Transfection-mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment.

Authors:  Alexander Plyusnin; Sami K J Kukkonen; Angelina Plyusnina; Olli Vapalahti; Antti Vaheri
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

6.  Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.

Authors:  L J Mitnaul; M N Matrosovich; M R Castrucci; A B Tuzikov; N V Bovin; D Kobasa; Y Kawaoka
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Computational analysis and determination of a highly conserved surface exposed segment in H5N1 avian flu and H1N1 swine flu neuraminidase.

Authors:  Ambarnil Ghosh; Ashesh Nandy; Papiya Nandy
Journal:  BMC Struct Biol       Date:  2010-02-22

8.  Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia.

Authors:  C Sibold; H Meisel; D H Krüger; M Labuda; J Lysy; O Kozuch; M Pejcoch; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  RNA structure and heterologous recombination in the double-stranded RNA bacteriophage phi 6.

Authors:  S Onodera; X Qiao; P Gottlieb; J Strassman; M Frilander; L Mindich
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Homologous RNA recombination in brome mosaic virus: AU-rich sequences decrease the accuracy of crossovers.

Authors:  P D Nagy; J J Bujarski
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.